Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis?
- PMID: 10847930
- DOI: 10.1016/s0167-6296(99)00014-4
Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis?
Abstract
This paper studies life-cycle preferences over consumption and health status. We show that cost-effectiveness analysis is consistent with cost-benefit analysis if the lifetime utility function is additive over time, multiplicative in the utility of consumption and the utility of health status, and if the utility of consumption is constant over time. We derive the conditions under which the lifetime utility function takes this form, both under expected utility theory and under rank-dependent utility theory, which is currently the most important nonexpected utility theory. If cost-effectiveness analysis is consistent with cost-benefit analysis, it is possible to derive tractable expressions for the willingness to pay for quality-adjusted life-years (QALYs). The willingness to pay for QALYs depends on wealth, remaining life expectancy, health status, and the possibilities for intertemporal substitution of consumption.
Comment in
-
Life-cycle preferences over consumption and health: a comment on Bleichrodt and Quiggin.J Health Econ. 2002 Jan;21(1):161-6; discussion 167-8. doi: 10.1016/s0167-6296(01)00120-5. J Health Econ. 2002. PMID: 11845922
Similar articles
-
Life-cycle preferences over consumption and health: a comment on Bleichrodt and Quiggin.J Health Econ. 2002 Jan;21(1):161-6; discussion 167-8. doi: 10.1016/s0167-6296(01)00120-5. J Health Econ. 2002. PMID: 11845922
-
A utility-theoretic model for QALYs and willingness to pay.Health Econ. 2003 Jan;12(1):17-31. doi: 10.1002/hec.697. Health Econ. 2003. PMID: 12483758
-
Cost-utility analysis from a societal perspective.Health Policy. 1997 Mar;39(3):241-53. doi: 10.1016/s0168-8510(96)00878-0. Health Policy. 1997. PMID: 10165464
-
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127. Pediatrics. 2005. PMID: 15867026 Review.
-
Discounting life-years: whither time preference?Health Econ. 1998 Mar;7(2):121-7. doi: 10.1002/(sici)1099-1050(199803)7:23.0.co;2-h. Health Econ. 1998. PMID: 9565168 Review.
Cited by
-
ESR/ERS statement paper on lung cancer screening.Eur Radiol. 2020 Jun;30(6):3277-3294. doi: 10.1007/s00330-020-06727-7. Epub 2020 Feb 12. Eur Radiol. 2020. PMID: 32052170 Review.
-
Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis.Clin Mol Allergy. 2017 Mar 7;15:5. doi: 10.1186/s12948-017-0058-3. eCollection 2017. Clin Mol Allergy. 2017. PMID: 28286421 Free PMC article. Review.
-
A cost-effectiveness analysis of using TheraBite in a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.Eur Arch Otorhinolaryngol. 2016 Mar;273(3):709-18. doi: 10.1007/s00405-015-3541-9. Epub 2015 Feb 11. Eur Arch Otorhinolaryngol. 2016. PMID: 25666587 Clinical Trial.
-
Healthcare reform: implications for knowledge translation in primary care.BMC Health Serv Res. 2013 Nov 25;13:490. doi: 10.1186/1472-6963-13-490. BMC Health Serv Res. 2013. PMID: 24274773 Free PMC article.
-
The value of a QALY: individual willingness to pay for health gains under risk.Pharmacoeconomics. 2014 Jan;32(1):75-86. doi: 10.1007/s40273-013-0110-1. Pharmacoeconomics. 2014. PMID: 24293198
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources